Return to Article Details Evaluation of Risk Markers Fluctuation During an Initial Therapy with Rosiglitazon in Patients Suffering from Metabolic Syndrome Download Download PDF
Themes by Openjournaltheme.com Themes by Openjournaltheme.com Themes by Openjournaltheme.com